Ideaya Biosciences Inc (IDYA) — Financial Flexibility Index
Ideaya Biosciences Inc (IDYA) has a Financial Flexibility Index of -0.80x as of March 2026. Free cash flow of $-74.20 Million (operating CF $-75.17 Million minus capex $967.00K) represents -1% of total liabilities ($93.08 Million). Check Ideaya Biosciences Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ideaya Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Ideaya Biosciences Inc across 9 annual periods. See IDYA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ideaya Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Ideaya Biosciences Inc. For the full company profile including market capitalisation, see Ideaya Biosciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.80x | $-68.73 Million | $-71.10 Million | $86.39 Million | ▲ +78.8% |
| 2024 | -3.75x | $-243.73 Million | $-247.58 Million | $64.94 Million | ▲ +6.1% |
| 2023 | -4.00x | $-112.86 Million | $-115.22 Million | $28.23 Million | ▼ -83.9% |
| 2022 | -2.17x | $-83.73 Million | $-87.17 Million | $38.51 Million | ▼ -226.6% |
| 2021 | -0.67x | $-53.13 Million | $-55.78 Million | $79.83 Million | ▼ -218.9% |
| 2020 | 0.56x | $55.96 Million | $55.46 Million | $100.00 Million | ▲ +118.6% |
| 2019 | -3.01x | $-37.96 Million | $-39.31 Million | $12.60 Million | ▼ -1591.4% |
| 2018 | -0.18x | $-25.91 Million | $-27.62 Million | $145.49 Million | ▲ +43.5% |
| 2017 | -0.32x | $-10.47 Million | $-12.22 Million | $33.22 Million | — |